CardioVisual

The next era of electrophysiology is being shaped by two major innovations in defibrillation therapy.

Extravascular ICD technology is creating new options that keep leads out of the vasculature, while advances in transvenous systems are reimagining what's possible through new capabilities such as physiologic pacing and defibrillation through the smallest-diameter lead available.

What do these developments mean for patient selection, long-term management, and the future of ICD therapy?

Join us LIVE as Trevor Cook, VP & General Manager at Medtronic, and Dr. Robert Canby, Electrophysiologist at Texas Cardiac Arrhythmia, discuss the technologies, the clinical evidence, and where they fit in practice today.

📅 July 16, 2026
⏰ 5:00 PM CT / 6:00 PM ET
📍 Live on

Follow so you don't miss the conversation.

Two innovation tracks are reshaping high-power therapy at once, and they're more connected than they look.

The extravascular EV-ICD provides patients with protection during defibrillation therapy while delivering anti-tachycardia pacing (ATP) when needed, all within a system that keeps the lead entirely out of the vasculature.

On the transvenous side, the newly launched OmniaSecure™ defibrillation lead became the first and only defibrillation lead approved by the FDA for placement in the left bundle branch area, which allows for conduction system pacing.

The real clinical question isn't whether one option is better than the other. Rather, it’s about which patients are best served by – and are candidates for – a system with a lead that never enters the vasculature and those who can benefit from a small-diameter lead that allows for physiologic pacing when paired with a traditional transvenous defibrillation system.

Join us on IG Live with Trevor Cook, VP & General Manager at Medtronic, moderated by Dr. Robert Canby, cardiac electrophysiologist, as we discuss where these technologies fit in clinical practice.

📅 Thursday, July 16
⏰ 5:00 PM CT
📍

Follow so you don't miss the conversation.

Resistant hypertension is the cue to look for a secondary cause. Here are four patterns worth recognizing on sight, each with the test that confirms it.

How many did you match on the first read?

Continue learning on the MedicalVisual clinician hub. Visit Hcp.medicalvisual.com!

Follow for clinically grounded, visual medical education.